BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03407170-completion@plaintrial.com
DTSTAMP:20261029T044828Z
DTSTART;VALUE=DATE:20190814
SUMMARY:Immunologic Determinants of Response to Pembrolizumab (MK-3475) in 
 Advanced Melanoma (MK-3475-161/KEYNOTE-161) — estimated completion date
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT03407170
URL:https://plaintrial.com/trial/NCT03407170
END:VEVENT
END:VCALENDAR
